Generalizations about relative prosodie boundary strength are recursive. Initial evidence comes from the fragment of English consisting only of proper names and and and or. A systematic relation ...

Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature assets are not reflective of its current capabilities. Read more here.

Taking Chomsky's Syntactic Structures as a starting point, this paper explores the use of recursive techniques in contemporary linguistic theory. Specifically, it is shown that there were profound ...

Long-distance cis-regulation of transcription is a natural consequence of recursive topological restraint. This new theory of chromatin structure has a multitude of consequences for key aspects of ...

Recursion uses a data-driven approach to drug discovery, launching four clinical trials in 2021 and planning a fifth in oncology. Click here to read more.

Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...